Condition

Nephrotic Syndrome in Children clinical trials and research

• 8Clinical trials
• 3Countries

Newest Nephrotic Syndrome in Children clinical trials

All recruiting trials (8)

• Dupilumab for nephrotic syndrome in children

  This study will try dupilumab to help children with steroid‑dependent or frequently relapsing nephrotic syndrome stay in remission and relapse less often.

  Recruiting at 2 sites Phase 2 National University Hospital, Singapore · Singapore, Singapore and 1 other locations · NCT07091175

• SG301 (anti-CD38) injection for children with frequently relapsing or steroid-dependent nephrotic syndrome

  This Phase 2 trial will test whether SG301 (an anti-CD38 antibody) injections are safe and help children aged 6–18 who have frequently relapsing or steroid‑dependent nephrotic syndrome.

  Recruiting Phase 2 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07087314

• Evaluating Telitacicept for Children with Nephrotic Syndrome

  This study is testing if a new treatment called telitacicept can help children with nephrotic syndrome feel better and have fewer side effects than the usual medications.

  Recruiting Phase 3 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06125405

• Using Adrenocorticotropic Hormone to Treat Children with Nephrotic Syndrome

  This study is testing if adding a hormone treatment to steroids can help children with nephrotic syndrome feel better and have fewer side effects.

  Recruiting at 8 sites Phase 3 The Children's Hospital of Zhejiang University School of Medicine · Wuhan, Hubei and 7 other locations · NCT06079788

• Vagus nerve stimulation for treating nephrotic syndrome in children

  This study is testing whether a new treatment using vagus nerve stimulation can help children aged 3 to 17 with nephrotic syndrome feel better and reduce their symptoms.

  Recruiting at 2 sites Northwell Health · New Hyde Park, New York and 1 other locations · NCT05588063

• Using vagus nerve stimulation to treat nephrotic syndrome in children

  This study is testing if a new type of nerve stimulation can help children with steroid-resistant nephrotic syndrome feel better over 26 weeks.

  Recruiting at 2 sites Northwell Health · New Hyde Park, New York and 1 other locations · NCT05583942

• Exploring experiences of patients and parents dealing with swelling from Nephrotic Syndrome

  This study talks to patients and parents about their experiences with swelling from Nephrotic Syndrome to help create better ways to measure how new treatments work.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT05505500

• NEPTUNE Match: Personalized matching of patients to kidney treatment options

  This project will try a system that matches people in the NEPTUNE cohort who have nephrotic syndromes or related kidney diseases with suitable clinical trials and shares those matches with patients and their doctors.

  Recruiting at 15 sites University of Michigan · Atlanta, Georgia and 15 other locations · NCT04571658

Related topics

Quick answers

How many Nephrotic Syndrome in Children clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (4 trials), China (3 trials), Singapore (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →